A detailed history of Profund Advisors LLC transactions in Agios Pharmaceuticals, Inc. stock. As of the latest transaction made, Profund Advisors LLC holds 18,111 shares of AGIO stock, worth $640,223. This represents 0.03% of its overall portfolio holdings.

Number of Shares
18,111
Previous 14,773 22.6%
Holding current value
$640,223
Previous $637,000 26.22%
% of portfolio
0.03%
Previous 0.02%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$41.19 - $49.72 $137,492 - $165,965
3,338 Added 22.6%
18,111 $804,000
Q2 2024

Aug 13, 2024

SELL
$27.55 - $48.83 $549,374 - $973,719
-19,941 Reduced 57.44%
14,773 $637,000
Q1 2024

May 08, 2024

BUY
$21.32 - $34.81 $195,205 - $318,720
9,156 Added 35.82%
34,714 $1.02 Million
Q4 2023

Feb 14, 2024

BUY
$19.97 - $24.53 $48,766 - $59,902
2,442 Added 10.56%
25,558 $569,000
Q3 2023

Nov 13, 2023

SELL
$24.36 - $28.18 $171,202 - $198,049
-7,028 Reduced 23.31%
23,116 $572,000
Q2 2023

Aug 10, 2023

SELL
$21.38 - $29.19 $179,164 - $244,612
-8,380 Reduced 21.75%
30,144 $853,000
Q1 2023

May 11, 2023

BUY
$21.74 - $30.93 $837,511 - $1.19 Million
38,524 New
38,524 $884,000
Q2 2022

Aug 01, 2022

SELL
$17.06 - $31.42 $142,826 - $263,048
-8,372 Closed
0 $0
Q1 2022

May 10, 2022

SELL
$26.68 - $34.81 $24,945 - $32,547
-935 Reduced 10.05%
8,372 $244,000
Q4 2021

Feb 08, 2022

SELL
$29.58 - $49.78 $58,627 - $98,663
-1,982 Reduced 17.56%
9,307 $306,000
Q3 2021

Nov 12, 2021

BUY
$41.92 - $58.18 $31,691 - $43,984
756 Added 7.18%
11,289 $521,000
Q2 2021

Aug 12, 2021

BUY
$52.06 - $61.27 $18,533 - $21,812
356 Added 3.5%
10,533 $580,000
Q1 2021

May 14, 2021

SELL
$44.23 - $57.5 $67,937 - $88,320
-1,536 Reduced 13.11%
10,177 $526,000
Q4 2020

Feb 09, 2021

BUY
$33.21 - $46.54 $34,804 - $48,773
1,048 Added 9.83%
11,713 $508,000
Q3 2020

Nov 13, 2020

SELL
$33.87 - $55.93 $93,786 - $154,870
-2,769 Reduced 20.61%
10,665 $373,000
Q2 2020

Aug 03, 2020

BUY
$34.45 - $53.48 $80,440 - $124,875
2,335 Added 21.04%
13,434 $718,000
Q1 2020

May 15, 2020

SELL
$31.52 - $53.81 $127,624 - $217,876
-4,049 Reduced 26.73%
11,099 $394,000
Q4 2019

Feb 18, 2020

BUY
$30.08 - $50.59 $97,729 - $164,366
3,249 Added 27.3%
15,148 $723,000
Q3 2019

Nov 12, 2019

SELL
$32.4 - $49.58 $22,161 - $33,912
-684 Reduced 5.44%
11,899 $386,000
Q2 2019

Aug 13, 2019

SELL
$46.17 - $68.1 $72,579 - $107,053
-1,572 Reduced 11.11%
12,583 $628,000
Q1 2019

May 15, 2019

BUY
$45.92 - $67.67 $12,122 - $17,864
264 Added 1.9%
14,155 $955,000
Q4 2018

Feb 14, 2019

SELL
$42.73 - $76.53 $143,145 - $256,375
-3,350 Reduced 19.43%
13,891 $641,000
Q3 2018

Nov 13, 2018

BUY
$71.67 - $91.95 $132,804 - $170,383
1,853 Added 12.04%
17,241 $1.33 Million
Q2 2018

Aug 13, 2018

SELL
$73.22 - $99.55 $35,658 - $48,480
-487 Reduced 3.07%
15,388 $1.3 Million
Q1 2018

May 14, 2018

BUY
$59.83 - $86.53 $38,829 - $56,157
649 Added 4.26%
15,875 $1.3 Million
Q4 2017

Feb 14, 2018

SELL
$52.12 - $72.33 $101,946 - $141,477
-1,956 Reduced 11.38%
15,226 $870,000
Q3 2017

Nov 13, 2017

BUY
$54.89 - $67.12 $66,471 - $81,282
1,211 Added 7.58%
17,182 $1.15 Million
Q2 2017

Aug 11, 2017

BUY
N/A
15,971
15,971 $822,000

Others Institutions Holding AGIO

About AGIOS PHARMACEUTICALS, INC.


  • Ticker AGIO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 54,818,000
  • Market Cap $1.94B
  • Description
  • Agios Pharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery and development of medicines in the field of cellular metabolism and adjacent areas of biology. The company offers PYRUKYND (mitapivat) an activator of both wild-type and a variety of mutant pyruvate kinase, PK, enzymes for the treatment of hemolytic anemias; and ...
More about AGIO
Track This Portfolio

Track Profund Advisors LLC Portfolio

Follow Profund Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Profund Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Profund Advisors LLC with notifications on news.